Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$299,779,562
+$39,670,446 QoQ
Shares Held
249,935
-11.6% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#214
of 4,605 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 58%
Shared 0%
None 42%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $3,542,546,853 across 13 Drug Manufacturers - General names. LLY ranks #5 (8.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
5,307,020 | $1,006,317,132 | |
| 2 | MRK |
Merck & Co., Inc.
|
3,966,523 | $509,698,205 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
8,585,846 | $494,716,446 | |
| 4 | NVO |
Novo Nordisk A S
|
8,270,785 | $396,501,432 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
249,935 | $299,779,562 | |
| 6 | JNJ |
Johnson & Johnson
|
1,127,893 | $286,450,985 | |
| 7 | ABBV |
AbbVie Inc.
|
856,797 | $215,604,397 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
959,904 | $121,274,271 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $299,779,562 | 249,935 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $260,109,116 | 282,798 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $180,187,313 | 167,666 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $76,607,489 | 100,403 | Shares | Defined | 2025-11-13 | |
| 2025-03-31 | $34,198,455 | 41,407 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $11,462,656 | 14,848 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,443,323,835 | 1,629,144 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,456,490,238 | 1,608,706 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $909,377,670 | 1,168,926 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $547,753,019 | 939,671 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $790,468,438 | 1,471,652 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $647,887,897 | 1,381,483 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $496,987,464 | 1,447,171 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $707,247,741 | 1,933,216 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $802,810,469 | 2,482,791 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,157,115,590 | 3,568,811 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $948,375,251 | 3,311,713 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $590,892,309 | 2,139,209 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $243,637,372 | 1,054,479 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $15,041,593 | 65,535 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $76,746,963 | 410,807 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $142,254,791 | 842,542 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $184,056,801 | 1,243,459 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $147,744,432 | 899,893 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $31,415,363 | 226,466 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||